Literature DB >> 11676993

Impaired oxidative metabolism in exercising muscle from ALS patients.

G Siciliano1, E Pastorini, L Pasquali, M L Manca, A Iudice, L Murri.   

Abstract

The pathogenic mechanism of selective loss of motor neurones in amyotrophic lateral sclerosis (ALS) is still poorly understood. Recently, research evidence has suggested that mitochondrial dysfunction occurs in central nervous system as well as in peripheral tissues from ALS patients. The aim of our study was to indirectly investigate in vivo oxidative metabolism of exercising muscle in a case history of patients affected by ALS. To this purpose 11 patients, 8 male and 3 female, mean age+/-SD: 52.4+/-11.1 years, performed a bicycle incremental test for the assessment of lactate production. At rest, there was increased lactate concentration in patients: 2.77+/-0.79 vs. 1.48+/-0.49 mmol/l in normal controls (normal range: 0.67-2.47 mmol/l). Analysis of lactate curve during exercise showed a lactate production increase compared to controls. Furthermore, anaerobic lactate threshold was detected at 40-50% of the predicted normal power output, anticipated with respect to both normal subjects and non-ALS chronically denervated controls with comparable motor impairment (60-70%), suggesting that mitochondrial dysfunction can occur in exercising skeletal muscle from ALS patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11676993     DOI: 10.1016/s0022-510x(01)00620-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression.

Authors:  Yajuan Xiao; Chehade Karam; Jianxun Yi; Lin Zhang; Xuejun Li; Dosuk Yoon; Huan Wang; Kamal Dhakal; Paul Ramlow; Tian Yu; Zhaohui Mo; Jianjie Ma; Jingsong Zhou
Journal:  Pharmacol Res       Date:  2018-09-18       Impact factor: 7.658

2.  Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Tesfaye Wolde Tefera; Katherine Bartlett; Shirley S Tran; Mark P Hodson; Karin Borges
Journal:  Mol Neurobiol       Date:  2019-01-26       Impact factor: 5.590

3.  Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study.

Authors:  Safa Al-Sarraj; Andrew King; Matt Cleveland; Pierre-François Pradat; Andrea Corse; Jeffrey D Rothstein; Peter Nigel Leigh; Bams Abila; Stewart Bates; Jens Wurthner; Vincent Meininger
Journal:  Acta Neuropathol Commun       Date:  2014-12-14       Impact factor: 7.801

4.  Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise.

Authors:  F Lanfranconi; A Ferri; G Corna; R Bonazzi; C Lunetta; V Silani; N Riva; A Rigamonti; A Maggiani; C Ferrarese; L Tremolizzo
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

Review 5.  Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions.

Authors:  Shyuan T Ngo; Jia D Mi; Robert D Henderson; Pamela A McCombe; Frederik J Steyn
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-07-25

6.  MG53 Preserves Neuromuscular Junction Integrity and Alleviates ALS Disease Progression.

Authors:  Jianxun Yi; Ang Li; Xuejun Li; Kiho Park; Xinyu Zhou; Frank Yi; Yajuan Xiao; Dosuk Yoon; Tao Tan; Lyle W Ostrow; Jianjie Ma; Jingsong Zhou
Journal:  Antioxidants (Basel)       Date:  2021-09-25

7.  Butyrate Ameliorates Mitochondrial Respiratory Capacity of The Motor-Neuron-like Cell Line NSC34-G93A, a Cellular Model for ALS.

Authors:  Xuejun Li; Li Dong; Ang Li; Jianxun Yi; Marco Brotto; Jingsong Zhou
Journal:  Biomolecules       Date:  2022-02-19

8.  The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.

Authors:  S T Ngo; F J Steyn
Journal:  Cell Regen (Lond)       Date:  2015-08-27

9.  TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS.

Authors:  Cristian A Droppelmann; Danae Campos-Melo; Alexander J Moszczynski; Hind Amzil; Michael J Strong
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

Review 10.  Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?

Authors:  Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle
Journal:  Cells       Date:  2021-03-02       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.